- ANI Pharmaceuticals press release (NASDAQ:ANIP): Q1 Non-GAAP EPS of $1.17 beats by $0.82.
- Revenue of $106.79M (+65.6% Y/Y) beats by $23.31M.
- Raises Company net revenue guidance to $385 million to $410 million from $360 million to $385 million vs $371.3M consensus; adjusted non-GAAP EBITDA guidance to $97 million to $107 million from $78 million to $88 million; adjusted non-GAAP earnings per share to $2.99 to $3.45 from $2.09 to $2.59 vs $2.43 consensus.
ANI Pharmaceuticals Non-GAAP EPS of $1.17 beats by $0.82, revenue of $106.79M beats by $23.31M
Recommended For You
About ANIP Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
ANIP | - | - |
ANI Pharmaceuticals, Inc. |